Skip to main content
Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.630
-0.007 (-1.11%)
Apr 29, 2026, 1:07 PM EDT - Market open

Silexion Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2013 FY 2012
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
Cash & Equivalents
5.991.194.60.791.6
Cash & Short-Term Investments
5.991.194.60.791.6
Cash Growth
404.72%-74.17%483.12%-50.69%-
Other Receivables
---0.090.16
Receivables
---0.090.16
Prepaid Expenses
0.570.970.340.01-
Restricted Cash
0.030.040.03--
Other Current Assets
0.050.060.020.040.03
Total Current Assets
6.642.254.980.931.79
Property, Plant & Equipment
0.440.560.250.010.01
Other Long-Term Assets
0.140.050.03--
Total Assets
7.222.865.260.941.8
Accounts Payable
0.790.930.320.10.08
Accrued Expenses
1.741.381.570.140.09
Short-Term Debt
-1---
Current Portion of Leases
0.180.160.11--
Current Income Taxes Payable
0.050.05---
Other Current Liabilities
-00.2--
Total Current Liabilities
2.763.522.20.240.17
Long-Term Debt
1.572.96---
Long-Term Leases
0.290.370.06--
Total Liabilities
4.616.852.260.240.17
Common Stock
0.040---
Additional Paid-In Capital
57.7339.2611.345.164.74
Retained Earnings
-55.17-43.25-26.81-4.47-3.11
Total Common Equity
2.6-3.99-15.480.71.63
Minority Interest
--3.42--
Shareholders' Equity
2.6-3.9930.71.63
Total Liabilities & Equity
7.222.865.260.941.8
Total Debt
2.044.490.17--
Net Cash (Debt)
3.96-3.34.420.791.6
Net Cash Growth
--461.42%-50.69%-
Net Cash Per Share
2.97-79.36---
Filing Date Shares Outstanding
3.330.56---
Total Common Shares Outstanding
3.130.12---
Working Capital
3.88-1.272.780.691.62
Book Value Per Share
0.83-32.37---
Tangible Book Value
2.6-3.99-15.480.71.63
Tangible Book Value Per Share
0.83-32.37---
Machinery
0.110.10.080.020.01
Leasehold Improvements
--0.06--
Source: S&P Capital IQ. Standard template. Financial Sources.